GeneDx Holdings Corp. Executives Sell Shares
閱讀少於1分鐘
| Reporter Name | Relationship | Type | Amount | SEC Filing |
|---|---|---|---|---|
| Stueland Katherine | Chief Executive Officer | Sell | $299,460 | Form 4 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | $490,854 | Form 4 |
GeneDx Holdings Corp. has reported significant stock transactions by its top executives. Katherine Stueland, the Chief Executive Officer, sold 3,220 shares of Class A Common Stock on July 9, 2025, at a price of $93.0 per share, totaling $299,460. Following the sale, Stueland directly owns 1,720 shares, with rights to 473,709 shares through restricted stock units and options to purchase 107,610 shares.
Kevin Feeley, the Chief Financial Officer, sold 5,278 shares of Class A Common Stock on the same day, at the same price of $93.0 per share, totaling $490,854. Post-transaction, Feeley directly owns 3,392 shares. His sale was conducted under a Rule 10b5-1 trading plan adopted on August 21, 2024.